共 50 条
- [22] Safety of Vedolizumab Alone or With Concomitant Corticosteroids and/or Immunosuppressants in Patients With Ulcerative Colitis or Crohn's Disease AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S478 - S478
- [23] Population pharmacokinetics of subcutaneous vedolizumab in Crohn's disease and Ulcerative Colitis JOURNAL OF CROHNS & COLITIS, 2025, 19 : I1256 - I1257
- [24] Real-world treatment persistence with vedolizumab in Crohn's disease and ulcerative colitis patients JOURNAL OF CROHNS & COLITIS, 2016, 10 : S173 - S174
- [25] Clinical Practice Experience With Subcutaneous Vedolizumab for the Treatment of Patients With Ulcerative Colitis and Crohn's Disease AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (12S): : S9 - S9
- [28] Efficacy and safety of vedolizumab in the treatment of ulcerative colitis Gastroenterologia y Hepatologia, 2016, 39 (10): : 677 - 686
- [29] Population pharmacokinetic modelling of vedolizumab in patients with ulcerative colitis or Crohn's disease JOURNAL OF CROHNS & COLITIS, 2014, 8 : S225 - S226
- [30] Questions and answers about the management of Crohn's disease and ulcerative colitis with vedolizumab GASTROENTEROLOGIA Y HEPATOLOGIA, 2019, 42 (10): : 650 - 656